🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the makers of Tylenol, claiming the firms hid potential risks that the medication created to pediatric brain development.

This legal action comes thirty days after Donald Trump publicized an unproven link between using acetaminophen - referred to as acetaminophen - during pregnancy and autism in offspring.

The attorney general is suing Johnson & Johnson, which previously sold the medication, the sole analgesic recommended for expectant mothers, and the current manufacturer, which currently produces it.

In a official comment, he claimed they "betrayed America by gaining financially from suffering and marketing drugs regardless of the potential hazards."

The manufacturer says there is insufficient reliable data linking Tylenol to autism.

"These companies misled for generations, deliberately risking millions to boost earnings," the attorney general, a Republican, declared.

Kenvue said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the reliability of acetaminophen and the possible consequences that could have on the well-being of US mothers and children."

On its online platform, Kenvue also mentioned it had "regularly reviewed the applicable studies and there is no credible data that demonstrates a verified association between consuming paracetamol and autism spectrum disorder."

Organizations speaking for doctors and healthcare providers concur.

ACOG has declared acetaminophen - the key substance in acetaminophen - is among limited choices for expectant mothers to treat discomfort and elevated temperature, which can pose significant medical dangers if not addressed.

"In over twenty years of studies on the utilization of acetaminophen in gestation, zero credible investigations has successfully concluded that the consumption of acetaminophen in any trimester of gestation causes brain development issues in young ones," the organization stated.

This legal action mentions latest statements from the former administration in arguing the drug is reportedly hazardous.

Recently, the former president generated worry from public health officials when he instructed pregnant women to "fight like hell" not to use Tylenol when unwell.

The US Food and Drug Administration then issued a notice that physicians should consider limiting the usage of Tylenol, while also declaring that "a proven link" between the medication and autism in minors has not been established.

Health Secretary RFK Jr, who oversees the Food and Drug Administration, had promised in spring to undertake "a massive testing and research effort" that would determine the origin of autism spectrum disorder in a matter of months.

But authorities advised that identifying a sole reason of autism - thought by researchers to be the consequence of a intricate combination of inherited and surrounding conditions - would prove challenging.

Autism spectrum disorder is a type of permanent neurological difference and condition that influences how persons experience and interact with the environment, and is diagnosed using physician assessments.

In his lawsuit, Paxton - a Trump ally who is campaigning for the Senate - claims Kenvue and Johnson & Johnson "willfully ignored and attempted to silence the science" around acetaminophen and autism spectrum disorder.

This legal action seeks to make the firms "eliminate any commercial messaging" that asserts acetaminophen is safe for expectant mothers.

The court case parallels the concerns of a assembly of parents of children with autism and attention deficit hyperactivity disorder who filed suit against the makers of acetaminophen in two years ago.

The court dismissed the lawsuit, saying investigations from the plaintiffs' authorities was not conclusive.